Orchid Chemicals & Pharmaceuticals Ltd on February 20, 2008 has announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets. The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
This is the 25th ANDA approval that the Company has received since it started its Us Generics journey in 2005.
The stock was trading at Rs.244, down by Rs.11.65 or 4.56%. The stock hit an intraday high of Rs.255.80 and low of Rs.242.
The total traded quantity was 34124 compared to 2 week average of 390045.
|
